The spotlight was on OraSure Technologies(NASDAQ:OSUR)
OraSure is launching the kit this month, and investors should be closely watching the product's sales in upcoming quarters. Health-care analysts Brenton Flynn and Max Macaluso discuss this catalyst.
One thing that's for sure is that a lot is riding on this product for OraSure. Keep in mind that while you can make huge gains investing in the biotech space, you can also suffer from huge losses. The best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you retire well and also reveal winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.
Max Macaluso, Brenton Flynn, and The Motley Fool have no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.